AVITA Medical (RCEL) Competitors

AVITA Medical (NASDAQ:RCEL) and National Vision (NASDAQ:EYE) are both small-cap medical companies, but which is the better business? We will compare the two companies based on the strength of their risk, community ranking, analyst recommendations, media sentiment, earnings, profitability, institutional ownership, dividends and valuation.

Is RCEL or EYE more profitable?

National Vision has a net margin of -0.81% compared to AVITA Medical's net margin of -96.26%. National Vision's return on equity of 3.52% beat AVITA Medical's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
AVITA Medical	-96.26%	-337.91%	-71.50%
National Vision	-0.81%	3.52%	1.39%

Does the media prefer RCEL or EYE?

In the previous week, National Vision had 9 more articles in the media than AVITA Medical. MarketBeat recorded 10 mentions for National Vision and 1 mentions for AVITA Medical. AVITA Medical's average media sentiment score of 1.89 beat National Vision's score of 1.06 indicating that AVITA Medical is being referred to more favorably in the media.

Company	Overall Sentiment
AVITA Medical	Very Positive
National Vision	Positive

Which has more volatility & risk, RCEL or EYE?

AVITA Medical has a beta of 1.6, indicating that its stock price is 60% more volatile than the S&P 500. Comparatively, National Vision has a beta of 1.22, indicating that its stock price is 22% more volatile than the S&P 500.

Do analysts rate RCEL or EYE?

AVITA Medical currently has a consensus price target of $17.25, suggesting a potential upside of 87.11%. National Vision has a consensus price target of $14.00, suggesting a potential upside of 10.05%. Given AVITA Medical's stronger consensus rating and higher possible upside, research analysts clearly believe AVITA Medical is more favorable than National Vision.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
AVITA Medical	0 Sell rating(s)	1 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.75
National Vision	0 Sell rating(s)	5 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.17

Which has better earnings & valuation, RCEL or EYE?

AVITA Medical has higher earnings, but lower revenue than National Vision. National Vision is trading at a lower price-to-earnings ratio than AVITA Medical, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
AVITA Medical	$64.25M	3.79	-$61.85M	-$2.39	-3.86
National Vision	$1.82B	0.55	-$65.90M	-$0.36	-35.34

Do institutionals and insiders hold more shares of RCEL or EYE?

27.7% of AVITA Medical shares are held by institutional investors. 1.8% of AVITA Medical shares are held by insiders. Comparatively, 2.3% of National Vision shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth.

Does the MarketBeat Community favor RCEL or EYE?

National Vision received 171 more outperform votes than AVITA Medical when rated by MarketBeat users. However, 70.34% of users gave AVITA Medical an outperform vote while only 64.80% of users gave National Vision an outperform vote.

Company	Underperform	Outperform
AVITA Medical	Outperform Votes 83 70.34%	Underperform Votes 35 29.66%
National Vision	Outperform Votes 254 64.80%	Underperform Votes 138 35.20%

Summary

AVITA Medical beats National Vision on 10 of the 18 factors compared between the two stocks.